You have no items in your shopping cart.
Close
    Filters
    Search

    TRI - ACTA H.A. MAXIMUM STRENGTH FORMULA - 300g

    SKU: 123389
    Ship to
    *
    *
    Shipping Method
    Name
    Estimated Delivery
    Price
    No shipping options
    Availability: In stock
    TRI-ACTA H.A. Maximum Strength with Hyaluronic Acid. TRI-ACTA is a combination of Glucosamine, Chondroitin and MSM, with Hyaluronic Acid when blended together, have a synergistic effect that enhances the synthesis of new cartilage, muscle tissue and ligaments. The synthesis of new cartilage treats the cartilage matrix at the cellular level, and allows the body to heal itself. Daily Supplement for Inflammed Joints designed to reduce inflammation, improve joint fluid viscosity and improve mobility. An excellent, long-term support formula for more intensive joint problems, such as arthritis or physical injury. Supports normalization of the synovial fluid viscosity (joint lubricant) in articulating joints. Each scoop contains: Glucosamine Sulfate 229 mg Glucosamine Hydrochloride 229 mg Methylsulfonylmethane (MSM) 450 mg Chondroitin Sulfate 85.5 mg Sodium Hyaluronate 6.5 mg
    TRI-ACTA H.A. Maximum Strength with Hyaluronic Acid. TRI-ACTA is a combination of Glucosamine, Chondroitin and MSM, with Hyaluronic Acid when blended together, have a synergistic effect that enhances the synthesis of new cartilage, muscle tissue and ligaments. The synthesis of new cartilage treats the cartilage matrix at the cellular level, and allows the body to heal itself. Daily Supplement for Inflammed Joints designed to reduce inflammation, improve joint fluid viscosity and improve mobility. An excellent, long-term support formula for more intensive joint problems, such as arthritis or physical injury. Supports normalization of the synovial fluid viscosity (joint lubricant) in articulating joints. Each scoop contains: Glucosamine Sulfate 229 mg Glucosamine Hydrochloride 229 mg Methylsulfonylmethane (MSM) 450 mg Chondroitin Sulfate 85.5 mg Sodium Hyaluronate 6.5 mg
    *
    *
    *